$0.5768
-0.0342-5.6%
Last update: Oct 28, 6:09 PM
Citius Oncology Inc (CTOR) Stock Price, Quote, News & History
CTORNASDAQ
HIVE Digital Technologies Ltd (NASDAQ: HIVE) rose in pre-market trading due to its subsidiary's new agreement. Other gainers include IP Strategy Holdings,...
You can purchase shares of Citius Oncology (NASDAQ:CTOR) through any online brokerage.
Other companies in Citius Oncology’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Citius Oncology has a consensus price target of $6.00.
The stock price for Citius Oncology (NASDAQ: CTOR) is $0.6 last updated October 28, 2026 at 6:09 PM EDT.
There are no upcoming dividends for Citius Oncology.
Citius Oncology does not have any upcoming earnings scheduled.
There is no upcoming split for Citius Oncology.
Citius Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies.The Company centers on achieving a market position by advancing therapies with reduced development and clinical risks, and...
